Plasma lysophosphatidic acid levels and hepatocellular carcinoma

Hepatology

Volumn 57, Issue 1, 2013, Pages 417-418

  Ikeda, Hitoshi ^a   Enooku, Kenichiro ^a   Ohkawa, Ryunosuke ^a   Koike, Kazuhiko ^a   Yatomi, Yutaka ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOTAXIN; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDYLCHOLINE;

BLOOD SAMPLING; CHRONIC LIVER DISEASE; ENZYME ACTIVITY; LETTER; LIPID BLOOD LEVEL; LIVER CELL CARCINOMA; LIVER FIBROSIS; OVARY CANCER; PRIORITY JOURNAL;

CARCINOMA, HEPATOCELLULAR; FIBROBLASTS; HUMANS; LIVER NEOPLASMS; LYSOPHOSPHOLIPIDS; MYOFIBROBLASTS;

EID: 84872126615     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.25886     Document Type: Letter

References (6)

1. Mazzocca A, Dituri F, Lupo L, Quaranta M, Antonaci S, Giannelli G. Tumor-secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblasts. HEPATOLOGY 2011; 54: 920-930.
2. Xu Y, Shen Z, Wiper DW, Wu M, Morton RE, Elson P, et al. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. JAMA 1998; 280: 719-723.
3. Baker DL, Morrison P, Miller B, Riely CA, Tolley B, Westermann AM, et al. Plasma lysophosphatidic acid concentration and ovarian cancer. JAMA 2002; 287: 3081-3082.
4. Nakamura K, Ohkawa R, Okubo S, Tozuka M, Okada M, Aoki S, et al. Measurement of lysophospholipase D/autotaxin activity in human serum samples. Clin Biochem 2007; 40: 274-277.
5. Watanabe N, Ikeda H, Nakamura K, Ohkawa R, Kume Y, Aoki J, et al. Both plasma lysophosphatidic acid and serum autotaxin levels are increased in chronic hepatitis C. J Clin Gastroenterol 2007; 41: 616-623.
6. Kremer AE, Martens JJ, Kulik W, Rueff F, Kuiper EM, van Buuren HR, et al. Lysophosphatidic acid is a potential mediator of cholestatic pruritus. Gastroenterology 2010; 139: 1008-1018.